Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The anti-inflammatory pathway with a local effect, exemplified by the cholinergic anti-inflammatory pathway (CAP), is an essential neuroimmune mechanism that regulates innate immunity at sites of injury or infection. It acts through neural signals (vagus nerve), neurotransmitters (acetylcholine), specific receptors on immune cells (α7-nAChR), leading to suppression of proinflammatory mediators while promoting resolution processes. Therapeutically targeting this system offers promising avenues for controlling pathological inflammation without broadly suppressing systemic immunity.
Vagus nerve stimulation, cholinergic agonists, and acetylcholinesterase inhibitors modulate the activity of immune cells through the α7 nicotinic acetylcholine receptor (α7-nAChR), leading to decreased production of pro-inflammatory cytokines like TNF-α and IL-1β by blocking NF-κB activation. Glucocorticoids, IL-10, and TGF-β act locally to dampen immune cell activity.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anti-inflammatory Pathway (Local Effect) (N/A).